当前位置:首页 - 行情中心 - 双鹭药业(002038) - 财务分析

双鹭药业

(002038)

  

流通市值:56.37亿  总市值:68.01亿
流通股本:8.52亿   总股本:10.27亿

双鹭药业(002038)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.18亿元,每股收益-0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益563818.91万元,未分配利润390692.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产591163.34万元,负债27344.43万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入540,562,431.05392,063,433.48245,116,238.481,018,358,696.85
营业总成本461,951,501.39261,700,152.08136,620,657.72765,793,318.81
营业利润-32,315,344.2418,484,775.9371,156,814.33477,869,983.57
利润总额-37,166,807.1318,481,831.7471,158,314.34464,894,309.39
净利润-17,745,874.2528,784,151.9969,675,806.49414,957,464.48
其他综合收益---12,807,829.6
综合收益总额-17,745,874.2528,784,151.9969,675,806.49427,765,294.08
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,204,724,372.872,415,088,082.812,675,312,708.262,639,981,026.24
非流动资产合计3,706,909,065.43,676,125,561.413,636,647,291.513,637,780,819.2
资产总计5,911,633,438.276,091,213,644.226,311,959,999.776,277,761,845.44
流动负债合计204,559,225.76178,473,302.22348,911,941.1373,326,272.29
非流动负债合计68,885,084.473,918,687.6583,334,749.8294,398,070.79
负债合计273,444,310.16252,391,989.87432,246,690.92467,724,343.08
归属于母公司股东权益合计5,629,778,019.035,830,206,101.475,870,750,718.225,800,616,100.16
股东权益合计5,638,189,128.115,838,821,654.355,879,713,308.855,810,037,502.36
负债和股东权益合计5,911,633,438.276,091,213,644.226,311,959,999.776,277,761,845.44
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计647,132,663.44474,582,868.7273,602,084.461,181,283,435.22
经营活动现金流出小计519,301,184.02338,777,654.31166,855,009.22721,086,138.72
经营活动产生的现金流量净额127,831,479.42135,805,214.39106,747,075.24460,197,296.5
投资活动现金流入小计329,700,097.7875,828,2593,300,000636,440,359.08
投资活动现金流出小计419,921,793.54102,796,429.4728,093,699.08981,090,791.25
投资活动产生的现金流量净额-90,221,695.76-26,968,170.47-24,793,699.08-344,650,432.17
筹资活动现金流入小计----
筹资活动现金流出小计154,102,500--102,735,000
筹资活动产生的现金流量净额-154,102,500---102,735,000
汇率变动对现金及现金等价物的影响-3.45-1.89-2.8332,957.83
现金及现金等价物净增加额-116,492,719.79108,837,042.0381,953,373.3312,844,822.16
期末现金及现金等价物余额423,550,721.97648,880,483.79621,996,815.09540,043,441.76
TOP↑